Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
about
The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?Old game, new players: Linking classical theories to new trends in transplant immunology.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.Sotrastaurin in liver transplantation: has it had a fair trial?Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
P2860
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Protein kinase C inhibitor sot ...... : a randomized phase II trial.
@en
type
label
Protein kinase C inhibitor sot ...... : a randomized phase II trial.
@en
prefLabel
Protein kinase C inhibitor sot ...... : a randomized phase II trial.
@en
P2093
P2860
P356
P1476
Protein kinase C inhibitor sot ...... : a randomized phase II trial.
@en
P2093
H Isoneimi
I Krishnan
J Pratschke
M Bijarnia
P De Simone
P2860
P304
P356
10.1111/AJT.13175
P407
P577
2015-02-12T00:00:00Z